Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patients

Zannoni Gian Franco; Improta Giuseppina; Pettinato Angela; Brunelli Chiara; Troncone Giancarlo; Scambia Giovanni; Fraggetta Filippo

首页> 外文期刊>Journal of Clinical Pathology >Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patients

【24h】

Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patients

机译：卵巢透明细胞癌中PI3KCA，KRAS和BRAF的分子状态：63例分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims To evaluate the incidence of PI3KCA, KRAS and BRAF mutations in primary ovarian clear cell carcinoma (OCCC).

机译：目的评估原发性卵巢透明细胞癌（OCCC）中PI3KCA，KRAS和BRAF突变的发生率。

著录项

来源
《Journal of Clinical Pathology》 |2016年第12期|1088-1092|共5页
作者
Zannoni Gian Franco; Improta Giuseppina; Pettinato Angela; Brunelli Chiara; Troncone Giancarlo; Scambia Giovanni; Fraggetta Filippo;
展开▼
作者单位

Univ Cattolica Sacro Cuore, Dept Pathol, Rome, Italy;

IRCCS, CROB, Lab Clin Res & Adv Diagnost, Rionero In Vulture, Italy;

Cannizzaro Hosp, Pathol Unit, Catania, Italy;

Univ Cattolica Sacro Cuore, Dept Pathol, Rome, Italy;

Univ Naples Federico II, Pathol Sect, Dept Publ Hlth, Naples, Italy;

Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, Rome, Italy;

Cannizzaro Hosp, Pathol Unit, Catania, Italy;

展开▼
收录信息美国《科学引文索引》(SCI);美国《化学文摘》(CA);
原文格式 PDF
正文语种 eng
中图分类
关键词
入库时间 2022-08-18 01:32:14

相似文献

外文文献
中文文献
专利

1. Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma [J] . ZannoniG.F., ImprotaG., ChiarelloG., Virchows Archiv: an international journal of pathology . 2014,第2期

机译：原发性透明细胞卵巢癌中KRAS，NRAS和BRAF的突变状态
2. Analysis of somatic mutations in BRAF, CDKN2A/p16 and PI3KCA in patients with medullary thyroid carcinoma [J] . Nascimento Fabricio P., Cardoso Mirian G., Lindsey Susan C., Molecular medicine reports . 2016,第2aPta1期

机译：甲状腺髓样癌患者BRAF，CDKN2A / p16和PI3KCA的体细胞突变分析
3. Analysis of somatic mutations in BRAF, CDKN2A/p16 and PI3KCA in patients with medullary thyroid carcinoma [J] . Nascimento Fabricio P., Cardoso Mirian G., Lindsey Susan C., Molecular medicine reports . 2016,第2aPta2期

机译：BRAF，CDKN2A / P16和PI3KCA中体细胞突变分析髓质甲状腺癌患者
4. Isolation of Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer Using Label-Free Microfluidic Technology for Enumeration and Detection of KRAS, BRAF, PIK3CA Mutation [C] . Haiyan Emily Liu, Evelyn Kidess-Sigal, Melanie Triboulet, International Molecular Medicine Tri-Conference. . 2016

机译：使用无标记微流体技术分离转移性结肠直肠癌患者的循环肿瘤细胞进行募准和检测KRA，BRAF，PIK3CA突变
5. BRAF gene status and the expression of growth factor signaling molecules in oral epithelial precursor lesions and squamous cell carcinoma [D] . TASHIRO KAZUKI 2019

机译：口腔上皮前体病变和鳞状细胞癌中BRAF基因的状态及生长因子信号分子的表达
6. KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions [O] . Kohei Nakamura, Kentaro Nakayama, Tomoka Ishibashi, 2016

机译：具有所有病理前体区域同步的卵巢低度浆液性癌的KRAS / BRAF分析
7. Analysis of somatic mutations in BRAF, CDKN2A/p16 and PI3KCA in patients with medullary thyroid carcinoma [O] . FABRÍCIO P. NASCIMENTO, MIRIAN G. CARDOSO, SUSAN C. LINDSEY, 2015

机译：BRAF，CDKN2A / P16和PI3KCA中体细胞突变分析髓质甲状腺癌患者

Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patients

摘要

著录项

相似文献

相关主题

期刊订阅